Samjin Pharmaceutical has appointed Kim Dae-hyun, former head of OTC marketing at Dongwha Pharmaceutical, as Executive Director to strengthen its Consumer Healthcare (CH) division.
Kim will oversee the CH division, focusing on enhancing the competitiveness of key brands such as 'Geborin' and 'Anjeong-yeok' while identifying new growth opportunities.
A graduate of Seoul National University’s College of Pharmacy, Kim has extensive experience in the field, having worked in hospitals and pharmacies before serving as the head of marketing planning at Hanmi Group's Online Farm and leading OTC marketing at Dongwha Pharmaceutical. He is recognized as an expert in the OTC and THC sectors, having led marketing strategies from product planning to execution.
During his tenure at Dongwha Pharmaceutical, Kim significantly boosted OTC sales and improved the company's market ranking based on IQVIA data. He also redefined the positioning of key brands through consumer data analysis, helping them achieve market-leading status.
Kim has demonstrated his capabilities in diversifying business by developing online and overseas distribution channels and exploring new categories such as dermacosmetics and pet healthcare.
Samjin Pharmaceutical plans to leverage Kim's expertise in market data analysis and consumer insights to enhance the market competitiveness of 'Geborin' and 'Anjeong-yeok' and create new growth momentum for its consumer healthcare business.
Kim Sang-jin, CEO of Samjin Pharmaceutical, stated, "We will strengthen brand competitiveness and discover new categories based on the experience and capabilities accumulated in the pharmaceutical industry to lead a resurgence in the consumer healthcare business."
Meanwhile, Samjin Pharmaceutical was co-founded in 1968 by former Chairman Jo Ui-hwan and Chairman Choi Seung-joo. Jo's son, Jo Gyu-hyuk, and Choi's daughter, Choi Ji-hyun, serve as co-CEOs. Choi's younger daughter, Choi Ji-sun, is also employed at the company. The Jo family holds 13.41% of Samjin Pharmaceutical's shares, while the Choi family owns 10.32%.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.